Inpatient versus Outpatient MRI? Outcomes for Hospitalized patients with New Liver Masses
Author:
Open Access
- 4 January 2025
- journal article
- research article
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (1) , 2-7
Abstract
No guidelines exist to guide hospitalists on whether inpatient MRI should be pursued for incidental liver masses. Here, we compare outcomes between patients who receive an inpatient MRI and those who did not, following detection of suspicious liver masses during hospitalization. A retrospective study of hospitalized patients with new HCC from Jan 1st, 2020 through Dec 31st, 2021 was conducted. Patients for hospice or with known HCC were excluded. Out of 34 unique subjects, 22 received MRI inpatient (IP) and 12 did not (non-IP). Time to inpatient MRI averaged 2.2 days. Inpatient LOS between the two groups were similar (6 v 7 days). IP group had lower lost-to-follow-up rates (4% v 42%). Median time to cancer treatment was similar (31 v 34 days), however IP group had higher treatment rate (68% v 42%). Obtaining inpatient MRI may benefit select high-risk patients, with increased follow-up rate and treatment rate for HCC.Keywords
This publication has 3 references indexed in Scilit:
- Discharge Outcomes of Hospitalized Patients with New Onset Decompensated CirrhosisDigestive Diseases and Sciences, 2024
- Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitalsPLOS ONE, 2019
- Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings CommitteeJournal of the American College of Radiology, 2017